BIOlogics in Severe Nasal POlyposis SurvEy

NCT05228041 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval)

Sponsor

University Hospital, Lille